Literature DB >> 30023130

Adjuvant therapy for resected pN2 non-small cell lung cancer: sequence is not all that matters.

Kristine E Kokeny1, Samual Francis1, Randa Tao1, Ying J Hitchcock1.   

Abstract

Entities:  

Year:  2018        PMID： 30023130      PMCID： PMC6036049          DOI： 10.21037/jtd.2018.05.152

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  10 in total

1.  Postoperative radiotherapy for pathologic N2 non-small-cell lung cancer treated with adjuvant chemotherapy: a review of the National Cancer Data Base.

Authors:  Cliff G Robinson; Aalok P Patel; Jeffrey D Bradley; Todd DeWees; Saiama N Waqar; Daniel Morgensztern; Maria Q Baggstrom; Ramaswamy Govindan; Jennifer M Bell; Tracey J Guthrie; Graham A Colditz; Traves D Crabtree; Daniel Kreisel; Alexander S Krupnick; G Alexander Patterson; Bryan F Meyers; Varun Puri
Journal:  J Clin Oncol       Date:  2015-02-09       Impact factor: 44.544

2.  Variations in target volume definition for postoperative radiotherapy in stage III non-small-cell lung cancer: analysis of an international contouring study.

Authors:  Femke O B Spoelstra; Suresh Senan; Cecile Le Péchoux; Satoshi Ishikura; Francesc Casas; David Ball; Allan Price; Dirk De Ruysscher; John R van Sörnsen de Koste
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-06-27       Impact factor: 7.038

3.  Tri-modality treatment in N2 stage IIIa non-small cell lung cancer: proper sequence remains unknown.

Authors:  Ze-Rui Zhao; Calvin S H Ng
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

4.  Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database.

Authors:  Brian E Lally; Daniel Zelterman; Joseph M Colasanto; Bruce G Haffty; Frank C Detterbeck; Lynn D Wilson
Journal:  J Clin Oncol       Date:  2006-06-12       Impact factor: 44.544

Review 5.  Postoperative radiotherapy for non-small cell lung cancer.

Authors:  Sarah Burdett; Larysa Rydzewska; Jayne Tierney; David Fisher; Mahesh Kb Parmar; Rodrigo Arriagada; Jean Pierre Pignon; Cecile Le Pechoux
Journal:  Cochrane Database Syst Rev       Date:  2016-10-11

6.  Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer.

Authors:  Rodrigo Arriagada; Bengt Bergman; Ariane Dunant; Thierry Le Chevalier; Jean-Pierre Pignon; Johan Vansteenkiste
Journal:  N Engl J Med       Date:  2004-01-22       Impact factor: 91.245

7.  Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial.

Authors:  Kathy S Albain; R Suzanne Swann; Valerie W Rusch; Andrew T Turrisi; Frances A Shepherd; Colum Smith; Yuhchyau Chen; Robert B Livingston; Richard H Feins; David R Gandara; Willard A Fry; Gail Darling; David H Johnson; Mark R Green; Robert C Miller; Joanne Ley; Willliam T Sause; James D Cox
Journal:  Lancet       Date:  2009-07-24       Impact factor: 79.321

8.  Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials. PORT Meta-analysis Trialists Group.

Authors: 
Journal:  Lancet       Date:  1998-07-25       Impact factor: 79.321

9.  Impact of postoperative radiation therapy on survival in patients with complete resection and stage I, II, or IIIA non-small-cell lung cancer treated with adjuvant chemotherapy: the adjuvant Navelbine International Trialist Association (ANITA) Randomized Trial.

Authors:  Jean-Yves Douillard; Rafael Rosell; Mario De Lena; Marcello Riggi; Patrick Hurteloup; Marc-Andre Mahe
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-04-24       Impact factor: 7.038

10.  Establishing the feasibility of the dosimetric compliance criteria of RTOG 1308: phase III randomized trial comparing overall survival after photon versus proton radiochemotherapy for inoperable stage II-IIIB NSCLC.

Authors:  Tawfik Giaddui; Wenzhou Chen; Jialu Yu; Liyong Lin; Charles B Simone; Lulin Yuan; Yutao U T Gong; Q Jackie Wu; Radhe Mohan; Xiaodong Zhang; Jaques B Bluett; Michael Gillin; Kevin Moore; Elizabeth O'Meara; Jennifer Presley; Jeffrey D Bradley; Zhongxing Liao; James Galvin; Ying Xiao
Journal:  Radiat Oncol       Date:  2016-05-04       Impact factor: 3.481
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.